Skip to main content
. 2017 Sep 8;125(9):097006. doi: 10.1289/EHP1015

Table 3.

Adjusted associations between standardized concentrations of pregnancy phenols and respiratory outcomes (n=587) and FEV1%(n=228) in boys.

Phenolc Wheezing (until age 5 y)a Asthma diagnosis (until age 5 y)a Bronchiolitis/Bronchitis (until age 3 y)a FEV1%b
HR (95% CI) phetd p-Value HR (95% CI) phetd p-Value HR (95% CI) phetd p-Value Beta (95% CI) phetd p-Value
2,4-Dichlorophenol                        
 Continuouse 1.06 (0.95, 1.19)   0.27 1.02 (0.87, 1.20)   0.79 0.98 (0.89, 1.08)   0.68 0.29 (0.94, 1.54)   0.64
 T1 1.00 0.64 0.74f 1.00 0.49 0.96f 1.00 0.50 0.40f 0.00 0.50 0.93f
 T2 1.16 (0.85, 1.58)     1.30 (0.83, 2.05)     1.08 (0.84, 1.38)     2.01 (1.57, 5.60)    
 T3 1.09 (0.81, 1.49)     1.07 (0.66, 1.72)     0.93 (0.73, 1.19)     0.45 (3.04, 3.94)    
2,5-Dichlorophenol                        
 Continuouse 1.08 (1.00, 1.17)   0.04 1.04 (0.93, 1.16)   0.52 1.00 (0.94, 1.07)   0.97 0.14 (0.71, 1.00)   0.74
 T1 1.00 0.01 0.13f 1.00 0.24 0.35f 1.00 0.82 0.54f 0.00 0.93 0.71f
 T2 1.66 (1.20, 2.28)     1.46 (0.90, 2.34)     1.03 (0.81, 1.33)     0.03 (3.58, 3.64)    
 T3 1.51 (1.10, 2.08)     1.41 (0.88, 2.25)     1.08 (0.85, 1.38)     0.59 (2.94, 4.11)    
Dichlorophenols                        
 Continuouse 1.08 (1.00, 1.17)   0.048 1.04 (0.92, 1.17)   0.55 1.00 (0.93, 1.07)   0.99 0.17 (0.72, 1.07)   0.70
 T1 1.00 0.03 0.08f 1.00 0.24 0.24f 1.00 0.76 0.47f 0.00 0.95 0.78f
 T2 1.45 (1.05, 1.99)     1.41 (0.87, 2.27)     1.00 (0.78, 1.29)     0.16 (3.81, 3.48)    
 T3 1.47 (1.07, 2.01)     1.45 (0.91, 2.32)     1.08 (0.85, 1.39)     0.38 (3.14, 3.91)    
Bisphenol A                        
 Continuouse 0.97 (0.82, 1.15)   0.75 1.23 (0.97, 1.55)   0.09 1.13 (0.99, 1.30)   0.08 0.51 (2.33, 1.32)   0.58
 T1 1.00 0.99 0.90f 1.00 0.28 0.12f 1.00 0.52 0.26f 0.00 0.46 0.62f
 T2 0.98 (0.72, 1.33)     1.04 (0.63, 1.71)     1.06 (0.83, 1.36)     2.20 (5.69, 1.27)    
 T3 0.98 (0.72, 1.34)     1.39 (0.87, 2.22)     1.15 (0.90, 1.48)     1.38 (4.99, 2.23)    
Benzophenone-3                        
 Continuouse 0.93 (0.86, 1.01)   0.08 0.97 (0.87, 1.09)   0.60 1.00 (0.94, 1.06)   0.91 0.42 (1.31, 0.47)   0.36
 T1 1.00 0.03 0.01f 1.00 0.26 0.16f 1.00 0.65 0.85f 0.00 0.83 0.56f
 T2 0.87 (0.65, 1.17)     0.81 (0.52, 1.26)     0.89 (0.70, 1.14)     0.60 (4.10, 2.90)    
 T3 0.66 (0.48, 0.91)     0.68 (0.42, 1.09)     0.93 (0.73, 1.19)     1.08 (4.55, 2.40)    
Triclosan                        
 Continuouse 0.98 (0.93, 1.03)   0.46 0.99 (0.92, 1.07)   0.86 1.00 (0.96, 1.04)   0.83 0.17 (0.40, 0.73)   0.56
 T1 1.00 0.79 0.57f 1.00 0.91 0.75f 1.00 0.80 0.62f 0.00 0.96 0.91f
 T2 0.94 (0.69, 1.27)     1.06 (0.67, 1.66)     1.05 (0.82, 1.34)     0.48 (2.97, 3.94)    
 T3 0.90 (0.67, 1.22)     0.96 (0.60, 1.52)     0.97 (0.76, 1.23)     0.69 (3.13, 3.84)    
Methyl-paraben                        
 Continuouse 0.92 (0.85, 1.00)   0.051 1.00 (0.89, 1.13)   0.99 0.94 (0.88, 1.00)   0.046 0.46 (1.30, 0.37)   0.28
 T1 1.00 0.03 0.17f 1.00 0.90 0.94f 1.00 0.02 0.01f 0.00 0.19 0.18f
 T2 0.68 (0.50, 0.92)     0.90 (0.57, 1.43)     0.80 (0.64, 1.03)     1.66 (1.89, 5.21)    
 T3 0.74 (0.55, 1.00)     0.99 (0.62, 1.58)     0.70 (0.54, 0.89)     1.63 (5.06, 1.78)    
Ethyl-paraben                        
 Continuouse 1.01 (0.95, 1.07)   0.72 1.10 (1.00, 1.21)   0.04 0.99 (0.94, 1.03)   0.53 0.59 (1.24, 0.05)   0.07
 T1 1.00 0.63 0.65f 1.00 0.047 0.08f 1.00 0.004 0.15f 0.00 0.52 0.31f
 T2 1.15 (0.85, 1.57)     1.66 (1.02, 2.71)     1.40 (1.10, 1.79)     1.13 (4.61, 2.36)    
 T3 1.13 (0.83, 1.55)     1.81 (1.10, 2.98)     0.97 (0.76, 1.26)     2.02 (5.51, 1.47)    
Propyl-paraben                        
 Continuouse 0.95 (0.89, 1.02)   0.14 0.99 (0.90, 1.09)   0.85 0.95 (0.91, 1.00)   0.08 0.22 (0.92, 0.49)   0.55
 T1 1.00 0.58 0.44f 1.00 0.91 0.89f 1.00 0.13 0.12f 0.00 0.63 0.38f
 T2 0.88 (0.66, 1.19)     0.91 (0.58, 1.45)     0.83 (0.65, 1.06)     0.43 (3.06, 3.91)    
 T3 0.86 (0.63, 1.17)     1.00 (0.63, 1.59)     0.79 (0.61, 1.00)     1.23 (4.71, 2.25)    
Butyl-paraben                        
 Continuouse 0.98 (0.92, 1.04)   0.49 1.01 (0.92, 1.11)   0.89 0.98 (0.93, 1.03)   0.36 0.41 (1.09, 0.27)   0.23
 T1 1.00 0.24 0.15f 1.00 0.59 0.68f 1.00 0.02 0.01f 0.00 0.30 0.15f
 T2 1.13 (0.84, 1.53)     1.26 (0.79, 2.01)     1.13 (0.89, 1.44)     1.07 (4.50, 2.36)    
 T3 0.86 (0.62, 1.20)     1.22 (0.75, 2.01)     0.79 (0.61, 1.03)     2.75 (6.26, 0.76)    
Parabens                        
 Continuouse 0.92 (0.85, 1.00)   0.05 1.00 (0.89, 1.13)   0.98 0.94 (0.88, 1.00)   0.054 0.46 (1.30, 0.38)   0.29
 T1 1.00 0.06 0.11f 1.00 0.94 0.75f 1.00 0.05 0.10f 0.00 0.06 0.13f
 T2 0.73 (0.54, 0.99)     0.95 (0.61, 1.50)     0.77 (0.61, 0.98)     2.58 (0.92, 6.09)    
 T3 0.73 (0.54, 0.99)     0.92 (0.57, 1.48)     0.77 (0.60, 0.98)     1.61 (5.04, 1.82)    

Note: CI, confidence interval; Dichlorophenols,molarsumofdichlorophenols(2,4-,2,5-dichlorophenols); FEV1%,forcedexpiratoryvolumein1sexpressedinpercentpredicted; HR, hazard rate; Parabens,molarsumofparabens (methyl-, ethyl-, propyl-, butyl-parabens); phet, p-values of heterogeneity; T, tertile.

a

Models adjusted for center, residence area, parental history of asthma or allergies, maternal ethnicity, maximal parental education level, maternal or passive smoking during pregnancy, postnatal passive smoking, older siblings, and child care. Missing values in covariates were imputed for at least one covariate in 277 boys, using the multiple imputation by chained equations multiple imputation method (100 imputations were performed).

b

Additionally adjusted for child’s height and age.

c

Standardized for urine sampling conditions (creatinine level, day and hour of sampling, gestational age, storage duration at room temperature and year of analysis), as detailed in Mortamais et al. (2012).

d

p-values of heterogeneity test.

e

Estimates for 1-unit increase in ln-transformed standardized concentration.

f

p-values of monotonic trend test.